NEWARK, Del., July 10, 2026 — The global Healthcare industry is witnessing growing demand for advanced sterilization monitoring solutions as hospitals, pharmaceutical manufacturers, and medical device companies reinforce infection prevention and regulatory compliance. According to Future Market Insights (FMI), the Biological Indicator Vial Market is projected to grow from USD 178.7...

The global Healthcare industry is witnessing rapid adoption of high-sensitivity diagnostic technologies as healthcare providers increasingly prioritize early disease detection, precision medicine, and quantitative biomarker analysis. According to Future Market Insights (FMI), the Digital Immunoassays Market is projected to grow from USD 2.4 billion in 2026 to USD 7.1 billion by 2036,...

According to the Latest Analysis by Future Market Insights (FMI), the Global Prostate-Specific Antigen (PSA) Testing Market is Expected to Witness Strong Growth Over the Next Decade, Driven by Rising Prostate Cancer Incidence, Advancements in AI-Driven Diagnostics, and Expanding Early Screening Programs The global Prostate-Specific Antigen (PSA) Testing Market is expected to grow significantly...

The global Point-of-Care Molecular Diagnostics Market is entering a high-growth phase as healthcare systems increasingly prioritize rapid, decentralized, and clinically accurate diagnostic solutions. Valued at USD 5.8 billion in 2026, the market is projected to reach USD 15.1 billion by 2036, expanding at a robust 10.0% CAGR during the forecast period. Growth is being fueled by rising demand...

According to the latest analysis by Future Market Insights (FMI), the global Lateral Flow Assays Market is poised for steady growth, driven by increasing demand for rapid diagnostic testing, expanding adoption of point-of-care healthcare solutions, rising prevalence of infectious diseases, and continuous advancements in digital diagnostic technologies. As healthcare systems worldwide emphasize...